To combat the problem of obesity, an increasing number of people are turning to glucagon-like peptide-1 (GLP-1) receptor agonists to help them lose weight faster and more easily. Currently, GLP-1 drugs are intended to treat type 2 diabetes, but many physicians are prescribing them off-label to also help with weight loss. Some GLP-1 drugs, such as Ozempic and Wegovy, have become popular due to their use by celebrities and influencers who promote their seemingly miraculous weight loss.
Unfortunately, GLP-1 drugs have led to serious gastrointestinal problems in some users. If you developed problems after using this type of drug, you might be eligible to seek compensation in nationwide GLP-1 lawsuits. Our dedicated legal team at LMD Injury Lawyers can review what happened to you. One of our attorneys could let you know if pursuing a legal claim is the best decision for you and your family. When appropriate, our firm partners with vetted co-counsel throughout the U.S., ensuring your case gets the full support and resources it deserves
Although many people praise how quickly and effectively Ozempic and other semaglutide medications work to combat obesity and diabetes, they could have dangerous side effects. While uncomfortable and annoying, some of the side effects are relatively minor and could be common with other weight loss medications, such as vomiting, nausea, diarrhea, stomach pain, and constipation. Other side effects could have long-term and debilitating effects on your life, including:
If you or your family member has experienced any persistent complications after taking a GLP-1 drug, you should meet with a doctor to discuss your symptoms. You should also consult with a knowledgeable attorney to learn about your legal options for complications with a GLP-1 drug.
After taking a GLP-1 drug and experiencing serious health problems, such as stomach paralysis, you might wonder if you have any legal options, such as filing a lawsuit. People have begun filing product liability lawsuits against Novo Nordisk, the maker of Ozempic, for creating an inherently defective and unsafe drug. In listing possible side effects when Ozempic was first manufactured and released to consumers, the drug manufacturer did not include gastroparesis.
The basis for the lawsuits is that the drug manufacturer knew or should have known about the risk of gastroparesis, yet the company failed to warn the public of the potential risk. In a legal claim resulting from a failure to warn, you would need to establish that the pharmaceutical company acted negligently by not releasing information about all possible dangerous side effects.
Our dedicated legal team can help you prove your case by collaborating closely with medical professionals and gathering sufficient scientific evidence to support your claim. Lawsuits involving GLP-1 drugs are not class actions; instead, they are an example of single multidistrict litigation (MDL). Essentially, all cases involving GLP-1 drugs have been consolidated for this initial stage of litigation into one court. This helps to make the process more efficient and to resolve initial issues that are common to all cases, such as whether there is scientific evidence to link GLP-1 drugs with gastroparesis.
Once the court has decided on all discovery and pretrial matters, the cases may each be returned to their own courts to be individually evaluated. Our skilled attorneys can help you understand the legal process and assist you in gathering evidence to prove your claim.
Many people take weight loss drugs to help improve their lives. If Ozempic, Wegovy, or another GLP-1 medication caused you to develop serious side effects, you should seek legal assistance. You may be eligible to file a GLP-1 lawsuit.
Speak with our experienced team at LMD Injury Lawyers to learn what legal options are currently available to you.
727-849-5353